Malignant Biliary Obstruction Clinical Trial
— DRAMBOOfficial title:
EUS - Guided Choledocho-duodenostomy Versus ERCP With Covered Metallic Stents in Patients With Unresectable Malignant Distal Common Bile Duct Strictures. A Multi-centred Randomised Controlled Trial
Verified date | August 2023 |
Source | Chinese University of Hong Kong |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
EUS - guided choledocho-duodenostomy (ECDS) is an established option for bile duct drainage in unresectable malignant distal CBD strictures when endoscopic retrograde cholangiopancreatography (ERCP) fails. However, how primary ECDS compares with ERCP with covered self-expanding metallic stents (CSEMS) in unresectable malignant distal CBD strictures is uncertain. The aim of the current study is to compare primary ECDS versus ERCP with CSEMS in unresectable malignant distal CBD strictures. We hypothesis that ECDS is associated with a higher 1-year stent patency rate.
Status | Completed |
Enrollment | 77 |
Est. completion date | December 2022 |
Est. primary completion date | December 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age = 18 years old with informed consent - Histologically (preferred) or radiologically confirmed distal malignant bile duct tumors - Inoperability by staging, comorbidities or patient wishes - Distal tumors 2cm away from the portal hilum - Bilirubin > 50umol/L at diagnosis Exclusion Criteria: - Multiple hepatic metastases with significant blockage of one or more liver segments (if no segment blockage, metastasis is not an exclusion criteria) - Presence of main portal vein thrombosis - Prior SEMS placement - Intraductal papillary mucinous carcinomas - Prior Billroth II or roux-en Y reconstruction - History of bleeding disorder or use of anticoagulation - Child's B/C cirrhosis - Pregnancy - Performance status ECOG =3 (confined to bed / chair > 50% waking hours) - Presence of other malignancy - Life expectancy < 3months |
Country | Name | City | State |
---|---|---|---|
Australia | Royal Prince Alfred Hospital | Sydney | |
Belgium | The University of Leuven | Leuven | |
China | Chinese University of Hong Kong | Hong Kong | Hong Kong |
Denmark | Aarhus University Hospital | Aarhus | |
Japan | Tokyo Medical University Hospital | Tokyo | |
Japan | Wakayama Medical University School of Medicine | Wakayama |
Lead Sponsor | Collaborator |
---|---|
Chinese University of Hong Kong | Kinki University, Tokyo Medical University |
Australia, Belgium, China, Denmark, Japan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | stent patency rate | Stent dysfunction is defined as radiology or endoscopy confirmed stent obstruction. | 1-year | |
Secondary | Technical success | Technical success is defined as the ability to access and drain the CBD by placement of a stent. | 1year | |
Secondary | Clinical success | Clinical success is defined as >30% drop in bilirubin levels | 1 year | |
Secondary | Adverse events | Adverse events related to the endoscopic procedures would be graded according to the lexicon of endoscopic adverse events | 30 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04941924 -
The ID- RFA Trial: A Trial of Intraductal Radio-frequency Ablation (ID-RFA) Plus Biliary Stenting Versus Biliary Stenting Alone for the Treatment of Malignant Biliary Obstruction.
|
N/A | |
Active, not recruiting |
NCT03672019 -
A Quality of Life Study in Patients Undergoing Percutaneous Biliary Drainage
|
||
Recruiting |
NCT05220475 -
A Comparison of a Fully Covered Self-expandable Metal Stent With an External Anchoring Plastic Stent and Uncovered Stent
|
N/A | |
Completed |
NCT02001779 -
IRS(Irradiation Stent) vs. CS(Conventional Stent) Insertion in Inoperable Malignant Biliary Obstruction
|
N/A | |
Not yet recruiting |
NCT06375954 -
EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)
|
N/A | |
Not yet recruiting |
NCT06375928 -
EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial)
|
N/A | |
Recruiting |
NCT05786326 -
Multihole Fully Covered Metallic Stents in the Management of Malignant Biliary Obstruction
|
N/A | |
Not yet recruiting |
NCT06375967 -
EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)
|
N/A | |
Completed |
NCT01869894 -
A Prospective Randomized Study for Efficacy of Uncovered Double Bare Metallic Stent Compared to Uncovered Single Bare Metallic Stent in Malignant Biliary Obstruction
|
N/A | |
Not yet recruiting |
NCT05804201 -
EUS-guided Hepatico-gastrostomy With Hot Giobor
|
N/A | |
Recruiting |
NCT01686425 -
Percutaneous Transhepatic Cholangiography Versus Endoscopic Ultrasound Guided Biliary Drainage
|
N/A | |
Recruiting |
NCT03215108 -
Comparison Between Novel Flower-type Covered Stent and Conventional Covered Stent
|
N/A | |
Recruiting |
NCT04898777 -
EUS-Guided Choledochoduodenostomy Versus ERCP for Primary Biliary Decompression in Distal Malignant Biliary Obstruction
|
N/A | |
Recruiting |
NCT05169398 -
EUS-guided Hepatico-gastrostomy Using a Novel Lumen Apposing Metal Stent
|
N/A | |
Enrolling by invitation |
NCT05233293 -
Spyglass+RFA Versus Cytobrush+RFA for Extrahepatic Cholangiocarcinoma
|
N/A | |
Completed |
NCT03812250 -
EUS-guided Biliary Drainage vs. ERCP Assisted Transpapillary Drainage for Malignant Biliary Obstruction
|
N/A | |
Recruiting |
NCT01073514 -
Clinical Trial of Bile Etiology ,Proteomics and Metabonomics of Malignant Biliary Obstruction
|
N/A | |
Recruiting |
NCT05142839 -
Palliation of Gastric Outflow Obstruction in Case of Concomitant Biliary Obstruction.
|
N/A | |
Recruiting |
NCT05729867 -
Efficacy and Safety of a Fully Covered Self-Expandable Metal Stent for Unresectable HCC
|
N/A | |
Completed |
NCT04405752 -
Evaluation of a New Metal Biliary Stent of 12-mm Diameter: a Case Control Study
|